ArdiOn: the AI engine for drug discovery platforms
Connect curated biomedical data, domain models, tools and experimental feedback in the reusable infrastructure layer behind Ardigen's scientific platforms.
ArdiOn is Ardigen’s AI engine for drug discovery. It provides the orchestration and application infrastructure used to assemble domain data, selected models and scientific workflows into a maintained platform. Each implementation is configured around the dataset, decisions, integrations and validation requirements of the use case.
Why generic AI infrastructure fails in drug discovery
Drug discovery data is multimodal, unevenly annotated and produced under changing experimental conditions. A platform may serve models and expose APIs while leaving scientists with brittle ingestion scripts, uncertain provenance and outputs that are difficult to review in context.
The operating problem becomes visible when a pipeline works for one dataset and fails on the next, when model inputs cannot be traced to their source or when new experimental results remain outside the system. Teams then spend time repairing handoffs instead of evaluating scientific evidence.
ArdiOn addresses the engine layer between curated domain data and a scientific application. The layer must connect data, models, tools and outputs while preserving the controls agreed for the platform.
What ArdiOn is
ArdiOn is Ardigen’s reusable data-to-decision engine for domain-specific scientific platforms. It provides a common architecture for ingestion, orchestration, model execution, application services and feedback from later experiments. The exact components depend on the platform being built.
Clients work with ArdiOn through an Ardigen platform or a scoped custom platform engagement. The discussion begins with the domain dataset, users and decisions the platform must support, followed by the models, integrations and operating controls required for delivery.
What teams can build on ArdiOn
Domain-specific AI platforms
Platforms tailored to a discovery domain such as morphological profiling, biologics design, or genomics, where dataset quality and engine infrastructure together drive value.
Automated ingestion and curation
Replace manual data preparation with automated, agentic, reproducible pipelines that keep your domain datasets current as new data arrives.
AI-LAB feedback loops
Connect predictions back to experimental results, so wet-lab validation re-enters model training and improves the next cycle.
Multi-model inference
Bring property prediction, generative design, and classification into one orchestrated workflow instead of a set of disconnected tools.
Production-grade deployment
Move from research-grade outputs to deployments that run reliably in R&D workflows, with appropriate data governance and access controls.
Collaboration in chat
Read and digest the data and AI outputs from your platform through a chat-like interface.
From dataset to decision: what each layer delivers
Domain dataset layer
Bring curated biomedical datasets, annotation schemes and provenance into a structure suitable for the approved scientific use case. Data-readiness criteria are defined before model execution begins.
Engine layer
Coordinate ingestion, model and tool calls, run state, interfaces and downstream application services. Approved client components can be included when their interfaces and validation status are understood.
Model layer
Run selected domain models for tasks such as prediction, classification, ranking or generation. Model versions, inputs, outputs and evaluation criteria are handled according to the implementation scope.
Insight layer
Present results in the form scientists need for review, such as ranked candidates, evidence views, confidence information or structured recommendations. The interface must preserve a traceable route back to data and model runs.
Where teams use ArdiOn
Morphological profiling (Ardigen phenAID): Ardigen’s AI-native platform for cell-painting and morphological profiling is built on ArdiOn. The engine provides automated ingestion of high-content imaging data, model orchestration across the Ardigen phenAID stack, and the infrastructure to connect experimental readouts back to discovery hypotheses.
Phenomics-based drug discovery (daGama, in development): Ardigen’s end-to-end platform for phenomics-based drug discovery with cell-painting data is a next platform to launch on ArdiOn.
Custom domain platform development: a biotech team with a proprietary dataset in a specialized domain, such as structural proteomics or single-cell transcriptomics, engages Ardigen to build a purpose-specific platform on ArdiOn. The dataset is structured, ingestion pipelines are established, and domain-specific models are deployed through the engine to deliver a production-grade application.
AI infrastructure modernization: a pharma R&D team running disconnected model tools and data scripts consolidates onto governed, orchestrated infrastructure. ArdiOn provides the engine layer that connects existing datasets and models into one platform with reproducible workflows and production-grade reliability.
Request a technical consultation.
Concrete, reusable deliverables
Domain platform on ArdiOn: a deployed, production-grade discovery platform that pairs your domain dataset with ArdiOn’s engine and Ardigen’s domain-specific models.
Automated ingestion pipelines: reproducible pipelines that keep your dataset current as experimental data is generated.
Orchestrated model infrastructure: an integrated multi-model workflow with adversarial output verification before results reach the scientist.
AI-LAB feedback loop: infrastructure for experimental results to re-enter model training, so the platform improves cycle over cycle.
Decision-ready output layer: a platform interface that surfaces ranked, confidence-scored insights instead of raw model output.
Documentation and governance: reproducible workflow documentation and access controls suited to R&D and regulated environments.
What changes for the team
Scientific confidence
Verified, domain-structured outputs carry documented confidence levels, so scientists spend less time triaging results before acting on them.
Operational efficiency
Automated ingestion and orchestrated inference replace the manual data prep and model management that consumes R&D capacity. Platforms stay current without hands-on pipeline maintenance.
Better decisions
The output layer is built around the choice a scientist actually makes next, not the probability a model happens to produce.
Reusable infrastructure
Platforms built on ArdiOn take on new datasets, models, and modalities without rebuilding the core. The engine stays stable while the domain layer extends.
Lower execution risk
Verified inputs and governed pipelines reduce the chance of poor-quality data reaching the decision point unchallenged.
Frequently Asked Questions
Is ArdiOn a product Ardigen sells, or internal infrastructure?
ArdiOn is Ardigen’s internal AI engine, the infrastructure layer used to build Ardigen’s domain-specific platforms. It is not sold as a standalone software license.
You engage with it through Ardigen’s platform products, such as Ardigen phenAID, or through a custom platform development engagement. If you are weighing your options, the useful conversation is about which platform you need and which domain dataset would power it.
What makes ArdiOn different from general-purpose AI infrastructure?
General-purpose platforms solve the last mile: model serving, APIs, dashboards. They do not solve the domain-specific data problem that comes first.
ArdiOn is built around drug discovery data, including sparse annotation, multimodal inputs, and experimental variability. It provides the ingestion, verification, and orchestration that general-purpose tools assume is already done. The result is a shorter path from domain dataset to a production-grade platform.
Can ArdiOn build platforms on our proprietary datasets?
For TCR-based and other immunotherapy programs where pHLA recognition is the mechanism of action, ARDiTox is integrated as a standard component of hit screening and lead selection – performing proteome-wide off-target epitope identification and generating a ranked safety score per candidate, in parallel with affinity and developability scoring.
How does ArdiOn handle model updates and experimental feedback?
ArdiOn supports AI-LAB feedback loops, the connection between computational predictions and experimental validation.
When wet-lab results confirm or contradict a prediction, that data re-enters the platform through automated ingestion and improves performance in later cycles. The specifics vary by platform and domain.
What AI and ML models does ArdiOn support?
ArdiOn orchestrates domain-specific models suited to each platform. That includes Ardigen-developed models, such as PRISM, Ardigen’s proprietary LLM for biological sequences used in biologics design, and established third-party models where appropriate.
The model layer is configured per platform rather than fixed at the engine level.
Related capabilities
Ardigen Biologics Discovery Platform
Biologics design and optimization powered by Ardigen’s AI infrastructure and proprietary models.
Agentic AI Research Environment
A connected, learning research environment across data, models, and workflows.
AI Model Development & Deployment
Designing, building, and deploying production-grade scientific models.
Consulting
Structured engagements for teams scoping platform architecture or infrastructure options.
Contact
Request a data architecture assessment
AI built on undocumented, inconsistent, or siloed data will stall, at scale if not in the pilot. The foundation is a tractable problem with a defined path, and the first step is understanding what the gap actually is.
Send us a message and we will contact you back within 48 hours.
Newsletter
Become an insider
Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!